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INTRODUCTION
Isolated non-compaction of the left ventricle (LVNC) is a
rare congenital cardiomyopathy. Recognized relatively re-
cently, it has been categorized as “unclassified cardiomy-
opathy” by the World Health Organization. It is caused by
failure of the developing myocardium to become compact,
thereby resulting in a “spongy myo-cardium”.
Embryology and development
Isolated LVNC is a rare disorder of endomyocardial
morphogenesis characterized by numerous prominent
ventricular trabeculations and deep intratrabecular re-
cesses (1). During normal embryonic development, en-
domyocardial trabeculations emerge from the apical re-
gion of the primitive ventricles at day 32 of fetal life (2),
and involute by day 70 through a process of resorption
and remodeling. LVNC is thought to be a failure of this
“compaction” process. It is thought to result from failure
of trabecular compaction of the loose mesh of muscle
fibers seen in the early stages of myocardial develop-
ment. Normally this process is more pronounced in the
left than in the right ventricle, resulting in a smooth, flat
endocardial surface. 
The normal left ventricle has less than three trabecu-
lations per imaging field, mostly confined to the lateral
wall (3). In this disorder, however, there are abnormal
trabeculations resulting from non-compaction scat-
tered all over the myocardium, but most evident near
the attachment of the papillary muscles of the mitral
valve (Fig. 1) (4). Right ventricular non-compaction may
accompany LVNC in <50% of patients. Due to the diffi-
culty in distinguishing normal variants in the highly tra-
beculated right ventricle from the pathological non-
compacted ventricle, several authors dispute the exis-
tence of right ventricular non-compaction (4, 5).
Isolated non-compaction of the ventricular myocardi-
um, first described by Chin et al (1) in 1990, is charac-
terized by persistent embryonic myocardial morphology
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found in the absence of other cardiac anomalies to ex-
plain the abnormal development. In such cases, the re-
sulting deep recesses communicate with the ventricular
cavity only, not the coronary circulation (1).
There is no specific histological finding in LNVC, al-
though fibrosis has been described in numerous reports
(6, 7) (Fig. 2). Some reports have observed necrotic my-
ocytes within the prominent trabeculations of patients
with non-compaction (5, 6).
Many cases of LVNC are caused by associated
anomalies that generate intraventricular pressure over-
load, as in the case of pulmonary atresia with intact ven-
tricular septum (8) or anomalous origin of the left coro-
nary artery from the pulmonary trunk (9). In these hearts,
the deep recesses are in continuity with the ventricular
cavity and with the coronary arteries; and therefore, are
more accurately described as persistent intramyocar-
dial sinusoids. By contrast, LVNC has no associated
cardiac lesions, and persistent sinusoids are not seen.
Genetics
The disorder can be sporadic, but familial recurrence
and associated dysmorphism has been reported (8, 9).
The familial form has a heterogenous mode of inheri-
tance. In the X-linked form of the disease, the locus has
been found on q28, and mutations have been reported
in the G4.5 gene (10, 11). This gene is in close proximity
to other genes responsible for myopathies, and a num-
ber of patients with hypertrabeculations have been
found to suffer from neuromuscular disorders such as
Emery-Dreifuss muscular dystrophy, Barth’s syndrome,
Becker’s muscular dystrophy, metabolic myopathies,
and Roifmann syndrome (12), skeletal abnormalities
such as Melnick-Needles syndrome and nail-patella
syndrome (13). The facial dysmorphism consists of
prominent forehead, strabismus, gothic palate or mi-
crognathia. 
In children, LVNC can occur in Barth’s syndrome, a
rare X-linked multi-system disorder caused by a muta-
tion in the G4.5 gene that encodes the tafazzin family of
proteins (14, 15). Mutations in this gene in adult LVNC
are rare, however, but mutations have been described in
adult LVNC in the genes encoding a-dystrobrevin and
Cypher/ZASP (14, 16), integral parts of the complex that
link the extracellular matrix of the myocardial cell to the
cytoskeleton.
Epidemiology
In the initial case series of isolated non-compaction
(1), the median age at diagnosis was 7 yrs (range 11
months to 22 yrs). Subsequent case reports have de-
scribed this finding in adults, including the elderly (1, 5,
17-19). In the largest series of patients with LVNC (5), the
prevalence was 0.014% of patients referred to the
echocardiography laboratory. The true prevalence is un-
clear since the correct diagnosis is often missed or de-
layed due to a lack of knowledge concerning this uncom-
mon disease, and its similarity to other diseases of the
myocardium and endocardium. Men appear to be affect-
ed more than women, accounting for 56-82% of cases in
the largest reported series of LVNC (1, 5, 20, 21).
Fig. 1 - Heart of a patient with LVNC.
Fig. 2 - Histological features of LVNC.Non-compaction of the ventricular myocardium
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Clinical features
Clinical severity depends on the extent of non-com-
pacted cardiac segments. Severe systolic heart failure
and increased end-diastolic pressure with restrictive
cardiomyopathy are seen in >50% of patients. Bundle
branch block, atrial arrhythmias and other serious ven-
tricular arrhythmias occur in 40% of cases and can
cause sudden cardiac death (11). Thromboembolic
complications have also been reported (10, 11). 
Diastolic dysfunction in ventricular non-compaction
can be related to both abnormal relaxation and restrictive
filling caused by the numerous prominent trabeculae (22).
The origin of systolic dysfunction in non-compaction is
unclear, but there is increasing evidence that subendocar-
dial hypoperfusion and microcirculatory dysfunction play
a role in ventricular dysfunction and arrhythmogenesis.
Chin et al (1) suggested that subendocardial perfusion
might be abnormal in LVNC despite the absence of epi-
cardial coronary artery disease. Due to the numerous
prominent trabeculae, subendocardial ischemia can be
the result of isometric contraction of the endocardium and
myocardium within the deep intertrabecular recesses.
Subendocardial perfusion defects have been described in
LVNC using cardiac magnetic resonance imaging (MRI)
(Fig. 3) (23). Positron emission tomography (PET) (24) and
scintigraphy with thallium-201 (21) have shown transmur-
al perfusion defects correlating with areas of non-com-
pacted myocardium in LVNC.
Abnormalities in resting ECG are found in the majori-
ty of patients with LVNC, but findings are non-specific
and include left ventricular (LV) hypertrophy, repolariza-
tion changes, inverted T waves, ST segment changes,
axis shifts, intraventricular conduction abnormalities
and AV block (1, 5, 20, 21). Electrocardiographic find-
ings of the Wolff-Parkinson-White syndrome have been
described in up to 15% of pediatric patients (21, 25),
but it was not observed in the two largest series of
adults with isolated non-compaction (5, 20).
Arrhythmias are common in patients with ventricular
non-compaction. Atrial fibrillation has been reported in
over 25% of adults with LVNC (5, 20). Ventricular tach-
yarrhythmias have been reported in as many as 47%.
Sudden cardiac death accounted for half of the deaths
in the larger series of patients with LVNC (1, 20). Al-
though ventricular arrhythmias occurred in nearly 40%
of patients in the initial description of LVNC by Chin et al
(1), Ichida et al (21) described no cases of ventricular
tachycardia or sudden death in the largest series of pe-
diatric patients with LVNC. Paroxysmal supraventricular
tachycardia and complete heart block have also been
reported in patients with LVNC (20, 21).
The occurrence of thromboembolic events, including
cerebrovascular accident, transient ischemic attack,
pulmonary embolism and mesenteric infarction, ranged
from 21-38% (5, 20). Embolic complications may be re-
lated to the development of thrombi in the extensively
trabeculated ventricle, depressed systolic function, or
the development of atrial fibrillation (20). Interestingly,
no systemic embolic events were reported in the largest
pediatric series with LVNC (21).
An association between non-compaction and neuro-
muscular disorders has also been described (3, 26), as
many as 82% of patients having some form of neuro-
muscular disorder. Chin et al described an association
between LVNC and facial dysmorphisms, including a
prominent forehead, strabismus, high-arching palate,
and micrognathia (1).
Diagnosis
Echocardiography is the best means for diagnosing
the disorder (4). The combined echocardiographic fea-
Fig. 3 - MRI of a patient with LVNC.Vizzardi et al
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tures essential for making a diagnosis include: a two-
layered ventricular myocardium consisting of an suben-
docardial compact layer and a thick non-compact en-
docardial layer with prominent trabeculations and intra-
trabecular recesses; continuity between the LV cavity
and the recesses with blood flowing in and out of the
ventricular cavity and absence of secondary causes of
increased trabeculations (Fig. 4) (13). There is continuity
between the LV cavity and the deep intratrabecular re-
cesses that are filled with blood from the ventricular
cavity, without evidence of communication with the epi-
cardial coronary artery system (1, 20).
The LV apical and inferior wall segments were in-
volved in all patients in an adult population with LVNC
studied by echocardiography (20). The right ventricular
apex was involved in 41% of patients. In the largest se-
ries of patients with LVNC (5), in addition to the apical
and mid-ventricular inferior wall segments, the mid-
ventricular lateral wall segment was involved in >80% of
patients. Hypokinesis was observed occasionally in
normally compacted segments as well as in the non-
compacted segments of the left ventricle (5), which may
correlate with the observation of microcirculatory dys-
function in both non-compacted and “normal” seg-
ments in patients with LVNC.
Chin et al (1) described a quantitative approach for
diagnosing non-compaction using a trabeculation peak
to trough ratio, but it has not been used widely in clini-
cal practice. Oechslin et al (5) and Jenni et al (4) de-
scribed the abnormally thickened myocardium as a two-
layered structure, with a normally compacted epicardial
layer and a thickened endocardial layer. They proposed
a quantitative evaluation for the diagnosis of LVNC by
determining the ratio of maximal thickness of the non-
compacted to compacted layers (measured at end sys-
tole in a parasternal short axis view), with a ratio of 2.0
diagnostic of LVNC. This technique allowed the differ-
entiation of the trabeculations of LVNC from that ob-
served with dilated cardiomyopathy or hypertensive
cardiomyopathy (4).
Based on echocardiographic studies, its prevalence
has been estimated at 0.05% in the general population
(20), and the finding of a ratio of 2.0 between the thick-
ness of the non-compacted and compacted myocardial
layers in systole is considered diagnostic (4).
Contrast echocardiography can be helpful when
standard echocardiographic image quality is limited or
the diagnosis is questionable (27). Prominent trabecula-
tions, apical hypertrophic cardiomyopathy, dilated car-
diomyopathy, arrhythmogenic right ventricular dyspla-
sia, endocardial fibroelastosis, cardiac metastasis, and
LV thrombus are important differential diagnostic con-
siderations.
Echocardiography can easily diagnose isolated ven-
tricular non-compaction if the echocardiographer is fa-
miliar with this congenital disorder, and if clear-cut di-
agnostic criteria are used. Due to the risk of familial oc-
currence, first-degree relatives should be screened by
echocardiography to identify asymptomatic patients.
Based on the ratio of end-diastolic thickness of the
non-compacted to compacted layers of the myocardi-
um, CMR imaging is accurate when diagnosing patho-
logical LVNC (28). The literature supports the clinical
use of CMR in diagnosing LVNC, especially for patients
with poor echocardiographic windows (29).
Fig. 4 - Echocardiographic aspect of LVNC.Non-compaction of the ventricular myocardium
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Ventriculography and computed tomography can al-
so show the typical morphological features of non-com-
paction: pathognomonic combination of multiple promi-
nent ventricular trabeculations and of multiple deep in-
tertrabecular recesses communicating with the ventric-
ular cavity.
Prognosis
The current literature suggests that LVNC in adults is
rare and associated with a poor prognosis (5, 30). In the
largest series to date, 48% of patients died or under-
went a heart transplant over a period of 44 months (5).
Prognosis in the asymptomatic patients was clearly bet-
ter than in the symptomatic patients (21).
The prognosis depends on the severity and is general-
ly grim due to cardiovascular complications such as con-
gestive failure (heart failure was caused by systolic and
diastolic dysfunction), shock, arrhythmias and fatal
thromboembolic events. The high prevalence of throm-
boembolic events (24% of patients) was consistent and
was independent of LV size or function (1). The deep re-
cesses can aggravate the risk of thrombus formation and
be an additional factor for this serious complication.
The cause of progressive myocardial failure has not
yet been elucidated. The hypertrophic segments are
perfused via the epicardial coronary arteries, which
have no continuity with the deep recesses communicat-
ing with the LV cavity. Thickened endocardium and is-
chemic lesions in prominent trabeculae surrounded by
deep trabecular recesses were documented in histolog-
ic specimens, which could be caused by ischemia (20).
Indeed, PET demonstrated restricted myocardial perfu-
sion in areas of LVNC (24). Hypothetically, both mor-
phology and vasomotion of the coronary vessels feed-
ing the hypertrophic segments can be abnormal with
subsequent ischemia. Progressive ischemia and subse-
quent scar tissue can be an arrhythmogenic substrate
for ventricular arrhythmias because the well-defined
morphologic substrate of LVNC cannot be considered
inherently arrhythmogenic. In severe cases, a heart
transplant may be the only option (1). 
Therapy
There is no specific option for the treatment of non-
compaction cardiomyopathy, which is the same as for
heart failure. Standard medical therapy for systolic and
diastolic ventricular dysfunction is warranted. Some
findings have pointed to the efficacy of carvedilol in im-
proving LV function, hypertrophy, and both metabolic
and adrenergic abnormalities in isolated LVNC (31). Car-
diac transplantation has been used for those with re-
fractory congestive heart failure. A more aggressive ap-
proach to the diagnosis and treatment of ventricular ar-
rhythmias may be justified, and assessment for atrial
and ventricular arrhythmias by ambulatory ECG moni-
toring should be performed annually. As more informa-
tion is gathered about LVNC and the risk of sudden car-
diac death, implantable defibrillator technology could
have an increased role. Biventricular pacemakers could
play a role in the treatment of LVNC patients with heart
failure, reduced LV function, and prolonged intraventric-
ular conduction. 
Prophylactic anticoagulation may be warranted be-
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